MedTrace Logo

Registry of Avance® Nerve Graft's Utilization and Recovery Outcomes Post Peripheral Nerve Reconstruction

NCT01526681 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 3126

Last updated 2026-01-26

No results posted yet for this study

Summary

This study is a registry of general use of Avance Nerve Graft and is intended to evaluate the uses, response rates, and safety of Avance Nerve Graft in the real-life clinical setting. Optional addendums 1 and 2 included in the protocol are intended to establish comparative groups and focused subgroups within the registry.

Conditions

  • Peripheral Nerve Injuries

Interventions

OTHER

Processed Human Nerve Graft

Implantation of appropriate length of processed human nerve graft at the time of surgery

OTHER

Standard Treatment, Autogenous Nerve Graft, Direct Suture, etc.

Historical control from established literature

OTHER

Autogenous Nerve Graft

Nerve gap reconstructions with autogenous nerve graft within the upper extremity

DEVICE

Nerve Tube Conduit

Nerve gap reconstructions with nerve tube conduit within the upper extremity

PROCEDURE

Autologous Breast Reconstruction with Neurotization

PROCEDURE

Autologous Breast Reconstruction without Neurotization

Sponsors & Collaborators

  • Axogen Corporation

    lead INDUSTRY

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-11-30
Primary Completion
2028-11-30
Completion
2028-11-30

Countries

  • United States
  • Austria
  • Canada
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01526681 on ClinicalTrials.gov